Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P33
Within normal range
vs 2Y Ago
-0.9x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -59.08% |
| 2023 | -14.87% |
| 2022 | 62.19% |
| 2021 | -74.88% |
| 2020 | -109.33% |
| 2019 | -425.29% |
| 2018 | -129.55% |
| 2017 | 185.54% |
| 2016 | -43.45% |
| 2015 | 34.46% |